Tecnazene

Tecnazene

SCHEMBL3014845

O=[N+]([O-])c1c(Cl)c(Cl)cc(Cl)c1Cl.O=[N+]([O-])c1c(Cl)c(Cl)cc(Cl)c1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 1.00
ALDH1A1 P00352 6/20 0.58
GRIN2D O15399 2/20 0.53
GRIN3B O60391 2/20 0.53
GRIN1 Q05586 2/20 0.53
GRIN2A Q12879 2/20 0.53
GRIN2B Q13224 2/20 0.53
GRIN2C Q14957 2/20 0.53
GRIN3A Q8TCU5 2/20 0.53
CYP3A4 P08684 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPK1 P28482 1/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
DCTPP1 Q9H773 2/20 0.41
CYP2C19 P33261 1/20 0.41
HPGD P15428 3/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tecnazene SCHEMBL64355 1.00 TSHR (1.00) TSHRALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL5579130 0.86 TSHR (0.75) TSHRALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL5921857 0.85 TSHR (0.74) TSHRALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL7607838 0.84 TSHR (0.72) TSHRALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL1625816 0.84 TSHR (0.72) TSHRALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL5064995 0.84 TSHR (0.72) TSHRALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL202953 0.84 TSHR (0.72) TSHRALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL203338 0.84 TSHR (0.72) TSHRALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL11125778 0.84 TSHR (0.72) TSHRALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL14211584 0.84 TSHR (0.72) TSHRALDH1A1GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492328-B2 Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2013-07-23 US disclosed
EP-2559771-A2 Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators Bristol-Myers Squibb Company (US) 2013-02-20 EP disclosed
US-20100184125-A1 BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO INSULIN GROWTH FACTOR-1 RECEPTOR MODULATORS BRISTOL-MYERS SQUIBB COMPANY 2010-07-22 US disclosed